EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma membrane damage limits cytoplasmic delivery by conventional cell penetrating peptides

Stéphanie G I Polderdijk iD, Jazeel F Limzerwala, Christoph Spiess iD

PLOS ONE · 03.09.2024 · 19 (9) · e0305848

DOI: 10.1371/journal.pone.0305848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 03.09.2024. Verfasst von Stéphanie G I Polderdijk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Antibody Engineering, Genentech Inc., South San Francisco, CA, United States of America. Hauptthemen laut MEDLINE: Cell-Penetrating Peptides, Cell Membrane, Cytoplasm. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Genentech.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intracellular delivery of large molecule cargo via cell penetrating peptides (CPPs) is an inefficient process and despite intense efforts in past decades, improvements in efficiency have been marginal. Utilizing a standardized and comparative analysis of the delivery efficiency of previously described cationic, anionic, and amphiphilic CPPs, we demonstrate that the delivery ceiling is accompanied by irreparable plasma membrane damage that is part of the uptake mechanism. As a consequence, intracellular delivery correlates with cell toxicity and is more efficient for smaller peptides than for large molecule cargo. The delivery of pharmaceutically relevant cargo quantities with acceptable toxicity thus seems hard to achieve with the CPPs tested in our study. Our results suggest that any engineered intracellular delivery system based on conventional cationic or amphiphilic CPPs, or the design principles underlying them, needs to accept low delivery yields due to toxicity limiting efficient cytoplasmic uptake. Novel peptide designs based on detailed study of uptake mechanisms are required to overcome these limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Penetrating PeptidesCell MembraneCytoplasmHumansDrug Delivery SystemsHeLa CellsAnimals

Substanzen

Cell-Penetrating Peptides

Autor:innen und Institutionen

  • Department of Antibody Engineering, Genentech Inc., South San Francisco, CA, United States of America.

ORCID-Profile: Stéphanie G I Polderdijk, Christoph Spiess

Förderung

  • Genentech

Zitieren

APA

Polderdijk, S. G. I., Limzerwala, J. F., & Spiess, C. (2024). Plasma membrane damage limits cytoplasmic delivery by conventional cell penetrating peptides. PLOS ONE, 19(9), e0305848. https://doi.org/10.1371/journal.pone.0305848

Vancouver

Polderdijk SGI, Limzerwala JF, Spiess C. Plasma membrane damage limits cytoplasmic delivery by conventional cell penetrating peptides. PLOS ONE. 2024;19(9):e0305848. doi:10.1371/journal.pone.0305848

BibTeX
@article{Polderdijk2024,
  author = {Polderdijk, Stéphanie G I and Limzerwala, Jazeel F and Spiess, Christoph},
  title = {Plasma membrane damage limits cytoplasmic delivery by conventional cell penetrating peptides},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {9},
  pages = {e0305848},
  doi = {10.1371/journal.pone.0305848}
}
Kostenlos starten →